About Teletype
Join
S
Sheetal
@sheetal
May 12, 2020

Global Anti-Infective Agents Market Value Get over USD 144.9 bn by 2020-2027

According to the Acumen Research and Consulting, the global Anti-Infective Agents market is expected to reach at USD 144.9 billion by 2026, along with the projected CAGR of 3.6% from 2020-2026.

The published report global Anti-Infective Agents market provides a holistic overview of the current market covering the current trends. The provided quantitative and qualitative data is based on the deeper analysis of the historical data and the current market situation that helps to provide an overview of the forecasted period.

Get Sample PDF @ https://www.acumenresearchandconsulting.com/request-sample/1281

The global Anti-Infective Agents market report provides deeper insights on the factors driving the global market along with the factors that are responsible to hamper the growth. In addition, the report provides the opportunities in the global Anti-Infective Agents market that would help the competitors to increase the profit share.

The global Anti-Infective Agents market report provides the quantitative information of the target segment that is covered in the report along with the regional data comparison.

The report provides an overview value chain analysis, Porters Five analysis, and cost structure analysis gives an idea of the industrial outlook. The global Anti-Infective Agents market report covers the data of the major geographical regions such as North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. In addition, the report also covers the country cross section providing deeper insights of the particular region.

The published global Anti-Infective Agents market report provides information about the major players operating in the target market. The company profile section provides important information about the major players, along with the financial overview, product segment revenue, the geographical presence of the company. It also provides information related to business development activities by the players such as merger & acquisition, partnerships and agreements.

The global Anti-Infective Agents market report also covers the products information that is offered by the particular players along with the specification. In addition, the player positioning based on their business strengths and product offerings which provides the competitive outlook of the industry.

Market participants

Abbott Laboratories, Astellas Pharma Inc., Bayer AG, Bristol-Myers Squibb Company, Gilead Sciences, Inc., GlaxoSmithKline plc., Johnson & Johnson Services, Inc., Merck & Co., Inc., Novartis AG, Pfizer, Inc., and Sanofi.

Market segmentation

Market Segmentation by Type:

  • Antibacterials
    • Cephalosporins
    • Penicillin
    • Fluoroquinolones
    • Macrolides
    • Carbapenem
    • Others
  • Antivirals
    • Azoles
    • Echinocandins
    • Polyenes
    • Others
  • Antifungals

Market Segmentation by Route of Administration:

  • Topical
  • Oral
  • IV
  • Others

Market Segmentation by Distribution Channel:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Specialty Pharmacies
  • E-Commerce
  • Others

Market Segmentation by Region:

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Table of content

CHAPTER 1. INDUSTRY OVERVIEW
1.1. Definition and Scope
1.1.1. Definition of Anti-Infective Agents
1.1.2. Market Segmentation
1.1.3. List of Abbreviations
1.2. Summary
1.2.1. Market Snapshot
1.2.2. Anti-Infective Agents Market By Type
1.2.2.1. Global Anti-Infective Agents Market Revenue and Growth Rate Comparison By Type (2015-2026)
1.2.2.2. Global Anti-Infective Agents Market Revenue Share By Type in 2017
1.2.2.3. Antibacterials
1.2.2.4. Antivirals
1.2.2.5. Antifungals
1.2.2.6. Others
1.2.3. Anti-Infective Agents Market By Route of Administration
1.2.3.1. Global Anti-Infective Agents Market Revenue and Growth Rate Comparison By Route of Administration (2015-2026)
1.2.3.2. Topical
1.2.3.3. Oral
1.2.3.4. IV
1.2.3.5. Others
1.2.4. Anti-Infective Agents Market By Distribution Channel
1.2.4.1. Global Anti-Infective Agents Market Revenue and Growth Rate Comparison By Distribution Channel (2015-2026)
1.2.4.2. Hospital Pharmacies
1.2.4.3. Retail Pharmacies
1.2.4.4. Specialty Pharmacies
1.2.4.5. E-Commerce
1.2.4.6. Others
1.2.5. Anti-Infective Agents Market by Geography
1.2.5.1. Global Anti-Infective Agents Market Revenue and Growth Rate Comparison by Geography (2015-2026)
1.2.5.2. North America Anti-Infective Agents Market Revenue and Growth Rate (2015-2026)
1.2.5.3. Europe Anti-Infective Agents Market Revenue and Growth Rate (2015-2026)
1.2.5.4. Asia-Pacific Anti-Infective Agents Market Revenue and Growth Rate (2015-2026)
1.2.5.5. Latin America Anti-Infective Agents Market Revenue and Growth Rate (2015-2026)
1.2.5.6. Middle East and Africa (MEA) Anti-Infective Agents Market Revenue and Growth Rate (2015-2026)
CHAPTER 2. MARKET DYNAMICS AND COMPETITION ANALYSIS
2.1. Market Drivers
2.2. Restraints and Challenges
2.3. Growth Opportunities
2.4. Porter’s Five Forces Analysis
2.4.1. Bargaining Power of Suppliers
2.4.2. Bargaining Power of Buyers
2.4.3. Threat of Substitute
2.4.4. Threat of New Entrants
2.4.5. Degree of Competition
2.5. Value Chain Analysis
2.6. Cost Structure Analysis
2.6.1. Raw Material and Suppliers
2.6.2. Manufacturing Process Analysis
2.7. Regulatory Compliance
2.8. Competitive Landscape, 2017
2.8.1. Player Positioning Analysis
2.8.2. Key Strategies Adopted By Leading Players
CHAPTER 3. MANUFACTURING PLANTS ANALYSIS
3.1. Capacity and Commercial Production Date of Global Anti-Infective Agents Major Manufacturers in 2017
3.2. Manufacturing Plants Distribution of Global Anti-Infective Agents Major Manufacturers in 2017
3.3. R&D Status and Technology Source of Global Anti-Infective Agents Major Manufacturers in 2017
3.4. Raw Materials Sources Analysis of Global Anti-Infective Agents Major Manufacturers in 2017
CHAPTER 4. ANTI-INFECTIVE AGENTS MARKET BY TYPE
4.1. Global Anti-Infective Agents Revenue By Type
4.2. Antibacterials
4.2.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
4.2.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
4.3. Antivirals
4.3.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
4.3.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
4.4. Antifungals
4.4.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
4.4.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
4.5. Other
4.5.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
4.5.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
CHAPTER 5. ANTI-INFECTIVE AGENTS MARKET BY ROUTE OF ADMINISTRATION
5.1. Global Anti-Infective Agents Revenue By Route of Administration
5.2. Topical
5.2.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
5.2.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
5.3. Oral
5.3.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
5.3.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
5.4. IV
5.4.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
5.4.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
5.5. Others
5.5.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
5.5.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
CHAPTER 6. ANTI-INFECTIVE AGENTS MARKET BY DISTRIBUTION CHANNEL
6.1. Global Anti-Infective Agents Revenue By Distribution Channel
6.2. Hospital Pharmacies
6.2.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
6.2.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
6.3. Retail Pharmacies
6.3.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
6.3.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
6.4. Specialty Pharmacies
6.4.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
6.4.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
6.5. E-Commerce
6.5.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
6.5.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
6.6. Others
6.6.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
6.6.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
CHAPTER 7. NORTH AMERICA ANTI-INFECTIVE AGENTS MARKET BY COUNTRY
7.1. North America Anti-Infective Agents Market Revenue and Growth Rate, 2015 – 2026 ($Million)
7.2. North America Anti-Infective Agents Market Revenue Share Comparison, 2015 & 2026 (%)
7.3. U.S.
7.3.1. U.S. Anti-Infective Agents Market Revenue and Forecast By Type, 2015 – 2026 ($Million)
7.3.2. Market Revenue and Forecast By Route of Administration, 2015 – 2026 ($Million)
7.3.3. Market Revenue and Forecast By Distribution Channel, 2015 – 2026 ($Million)
7.4. Canada
7.4.1. Market Revenue and Forecast By Type, 2015 – 2026 ($Million)
7.4.2. Market Revenue and Forecast By Route of Administration, 2015 – 2026 ($Million)
7.4.3. Market Revenue and Forecast By Distribution Channel, 2015 – 2026 ($Million)
7.5. Mexico
7.5.1. Market Revenue and Forecast By Type, 2015 – 2026 ($Million)
7.5.2. Market Revenue and Forecast By Route of Administration, 2015 – 2026 ($Million)
7.5.3. Market Revenue and Forecast By Distribution Channel, 2015 – 2026 ($Million)
CHAPTER 8. EUROPE ANTI-INFECTIVE AGENTS MARKET BY COUNTRY
8.1. Europe Anti-Infective Agents Market Revenue and Growth Rate, 2015 – 2026 ($Million)
8.2. Europe Anti-Infective Agents Market Revenue Share Comparison, 2015 & 2026 (%)
8.3. UK
8.3.1. Market Revenue and Forecast By Type, 2015 – 2026 ($Million)
8.3.2. Market Revenue and Forecast By Route of Administration, 2015 – 2026 ($Million)
8.3.3. Market Revenue and Forecast By Distribution Channel, 2015 – 2026 ($Million)
8.4. Germany
8.4.1. Market Revenue and Forecast By Type, 2015 – 2026 ($Million)
8.4.2. Market Revenue and Forecast By Route of Administration, 2015 – 2026 ($Million)
8.4.3. Market Revenue and Forecast By Distribution Channel, 2015 – 2026 ($Million)
8.5. France
8.5.1. Market Revenue and Forecast By Type, 2015 – 2026 ($Million)
8.5.2. Market Revenue and Forecast By Route of Administration, 2015 – 2026 ($Million)
8.5.3. Market Revenue and Forecast By Distribution Channel, 2015 – 2026 ($Million)
8.6. Spain
8.6.1. Market Revenue and Forecast By Type, 2015 – 2026 ($Million)
8.6.2. Market Revenue and Forecast By Route of Administration, 2015 – 2026 ($Million)
8.6.3. Market Revenue and Forecast By Distribution Channel, 2015 – 2026 ($Million)
8.7. Rest of Europe
8.7.1. Market Revenue and Forecast By Type, 2015 – 2026 ($Million)
8.7.2. Market Revenue and Forecast By Route of Administration, 2015 – 2026 ($Million)
8.7.3. Market Revenue and Forecast By Distribution Channel, 2015 – 2026 ($Million)
CHAPTER 9. ASIA-PACIFIC ANTI-INFECTIVE AGENTS MARKET BY COUNTRY
9.1. Asia-Pacific Anti-Infective Agents Market Revenue and Growth Rate, 2015 – 2026 ($Million)
9.2. Asia-Pacific Anti-Infective Agents Market Revenue Share Comparison, 2015 & 2026 (%)
9.3. China
9.3.1. Market Revenue and Forecast By Type, 2015 – 2026 ($Million)
9.3.2. Market Revenue and Forecast By Route of Administration, 2015 – 2026 ($Million)
9.3.3. Market Revenue and Forecast By Distribution Channel, 2015 – 2026 ($Million)
9.4. Japan
9.4.1. Market Revenue and Forecast By Type, 2015 – 2026 ($Million)
9.4.2. Market Revenue and Forecast By Route of Administration, 2015 – 2026 ($Million)
9.4.3. Market Revenue and Forecast By Distribution Channel, 2015 – 2026 ($Million)
9.5. India
9.5.1. Market Revenue and Forecast By Type, 2015 – 2026 ($Million)
9.5.2. Market Revenue and Forecast By Route of Administration, 2015 – 2026 ($Million)
9.5.3. Market Revenue and Forecast By Distribution Channel, 2015 – 2026 ($Million)
9.6. Australia
9.6.1. Market Revenue and Forecast By Type, 2015 – 2026 ($Million)
9.6.2. Market Revenue and Forecast By Route of Administration, 2015 – 2026 ($Million)
9.6.3. Market Revenue and Forecast By Distribution Channel, 2015 – 2026 ($Million)
9.7. South Korea
9.7.1. Market Revenue and Forecast By Type, 2015 – 2026 ($Million)
9.7.2. Market Revenue and Forecast By Route of Administration, 2015 – 2026 ($Million)
9.7.3. Market Revenue and Forecast By Distribution Channel, 2015 – 2026 ($Million)
9.8. Rest of Asia-Pacific
9.8.1. Market Revenue and Forecast By Type, 2015 – 2026 ($Million)
9.8.2. Market Revenue and Forecast By Route of Administration, 2015 – 2026 ($Million)
9.8.3. Market Revenue and Forecast By Distribution Channel, 2015 – 2026 ($Million)
CHAPTER 10. LATIN AMERICA ANTI-INFECTIVE AGENTS MARKET BY COUNTRY
10.1. Latin America Anti-Infective Agents Market Revenue and Growth Rate, 2015 – 2026 ($Million)
10.2. Latin America Anti-Infective Agents Market Revenue Share Comparison, 2015 & 2026 (%)
10.3. Brazil
10.3.1. Market Revenue and Forecast By Type, 2015 – 2026 ($Million)
10.3.2. Market Revenue and Forecast By Route of Administration, 2015 – 2026 ($Million)
10.3.3. Market Revenue and Forecast By Distribution Channel, 2015 – 2026 ($Million)
10.4. Argentina
10.4.1. Market Revenue and Forecast By Type, 2015 – 2026 ($Million)
10.4.2. Market Revenue and Forecast By Route of Administration, 2015 – 2026 ($Million)
10.4.3. Market Revenue and Forecast By Distribution Channel, 2015 – 2026 ($Million)
10.5. Rest of Latin America
10.5.1. Market Revenue and Forecast By Type, 2015 – 2026 ($Million)
10.5.2. Market Revenue and Forecast By Route of Administration, 2015 – 2026 ($Million)
10.5.3. Market Revenue and Forecast By Distribution Channel, 2015 – 2026 ($Million)
CHAPTER 11. MIDDLE EAST ANTI-INFECTIVE AGENTS MARKET BY COUNTRY
11.1. Middle East Anti-Infective Agents Market Revenue and Growth Rate, 2015 – 2026 ($Million)
11.2. Middle East Anti-Infective Agents Market Revenue Share Comparison, 2015 & 2026 (%)
11.3. Saudi Arabia
11.3.1. Market Revenue and Forecast By Type, 2015 – 2026 ($Million)
11.3.2. Market Revenue and Forecast By Route of Administration, 2015 – 2026 ($Million)
11.3.3. Market Revenue and Forecast By Distribution Channel, 2015 – 2026 ($Million)
11.4. UAE
11.4.1. Market Revenue and Forecast By Type, 2015 – 2026 ($Million)
11.4.2. Market Revenue and Forecast By Route of Administration, 2015 – 2026 ($Million)
11.4.3. Market Revenue and Forecast By Distribution Channel, 2015 – 2026 ($Million)
11.5. Rest of Middle East
11.5.1. Market Revenue and Forecast By Type, 2015 – 2026 ($Million)
11.5.2. Market Revenue and Forecast By Route of Administration, 2015 – 2026 ($Million)
11.5.3. Market Revenue and Forecast By Distribution Channel, 2015 – 2026 ($Million)
CHAPTER 12. AFRICA ANTI-INFECTIVE AGENTS MARKET BY COUNTRY
12.1. Africa Anti-Infective Agents Market Revenue and Growth Rate, 2015 – 2026 ($Million)
12.2. Africa Anti-Infective Agents Market Revenue Share Comparison, 2015 & 2026 (%)
12.3. South Africa
12.3.1. Market Revenue and Forecast By Type, 2015 – 2026 ($Million)
12.3.2. Market Revenue and Forecast By Route of Administration, 2015 – 2026 ($Million)
12.3.3. Market Revenue and Forecast By Distribution Channel, 2015 – 2026 ($Million)
12.4. Egypt
12.4.1. Market Revenue and Forecast By Type, 2015 – 2026 ($Million)
12.4.2. Market Revenue and Forecast By Route of Administration, 2015 – 2026 ($Million)
12.4.3. Market Revenue and Forecast By Distribution Channel, 2015 – 2026 ($Million)
12.5. Rest of Africa
12.5.1. Market Revenue and Forecast By Type, 2015 – 2026 ($Million)
12.5.2. Market Revenue and Forecast By Route of Administration, 2015 – 2026 ($Million)
12.5.3. Market Revenue and Forecast By Distribution Channel, 2015 – 2026 ($Million)
CHAPTER 13. COMPANY PROFILE
13.1. Abbott Laboratories
13.1.1. Company Snapshot
13.1.2. Overview
13.1.3. Financial Overview
13.1.4. Type Portfolio
13.1.5. Key Developments
13.1.6. Strategies
13.2. Astellas Pharma Inc.
13.2.1. Company Snapshot
13.2.2. Overview
13.2.3. Financial Overview
13.2.4. Type Portfolio
13.2.5. Key Developments
13.2.6. Strategies
13.3. Bayer AG
13.3.1. Company Snapshot
13.3.2. Overview
13.3.3. Financial Overview
13.3.4. Type Portfolio
13.3.5. Key Developments
13.3.6. Strategies
13.4. Bristol-Myers Squibb Company
13.4.1. Company Snapshot
13.4.2. Overview
13.4.3. Financial Overview
13.4.4. Type Portfolio
13.4.5. Key Developments
13.4.6. Strategies
13.5. Gilead Sciences, Inc.
13.5.1. Company Snapshot
13.5.2. Overview
13.5.3. Financial Overview
13.5.4. Type Portfolio
13.5.5. Key Developments
13.5.6. Strategies
13.6. GlaxoSmithKline plc.
13.6.1. Company Snapshot
13.6.2. Overview
13.6.3. Financial Overview
13.6.4. Type Portfolio
13.6.5. Key Developments
13.6.6. Strategies
13.7. Johnson & Johnson Services, Inc.
13.7.1. Company Snapshot
13.7.2. Overview
13.7.3. Financial Overview
13.7.4. Type Portfolio
13.7.5. Key Developments
13.7.6. Strategies
13.8. Merck & Co., Inc.
13.8.1. Company Snapshot
13.8.2. Overview
13.8.3. Financial Overview
13.8.4. Type Portfolio
13.8.5. Key Developments
13.8.6. Strategies
13.9. Novartis AG
13.9.1. Company Snapshot
13.9.2. Overview
13.9.3. Financial Overview
13.9.4. Type Portfolio
13.9.5. Key Developments
13.9.6. Strategies
13.10. Pfizer, Inc.
13.10.1. Company Snapshot
13.10.2. Overview
13.10.3. Financial Overview
13.10.4. Type Portfolio
13.10.5. Key Developments
13.10.6. Strategies
13.11. Sanofi
13.11.1. Company Snapshot
13.11.2. Overview
13.11.3. Financial Overview
13.11.4. Type Portfolio
13.11.5. Key Developments
13.11.6. Strategies
13.12. Others
13.12.1. Company Snapshot
13.12.2. Overview
13.12.3. Financial Overview
13.12.4. Type Portfolio
13.12.5. Key Developments
13.12.6. Strategies
CHAPTER 14. RESEARCH APPROACH
14.1. Research Methodology
14.1.1. Initial Data Search
14.1.2. Secondary Research
14.1.3. Primary Research
14.2. Assumptions and Scope

Buy this premium report @ https://www.acumenresearchandconsulting.com/buy-now/0/1281

Contact us:

Sheetal k

Email: [email protected]

Phone: +14079154157 | +14089009135

Website: https://www.acumenresearchandconsulting.com

Acumen Research and Consulting (ARC)
May 12, 2020, 12:58
0 reactions
0 views